About Onea Clinical Services
Starting with the Sponsor’s Development Questions, Turning Evidence into Better-Supported Study Design and Development Decisions
Onea Clinical is a Sponsor-side clinical development service of Onea Biotech, focused on critical development work spanning development readiness, Pre-IND / FIH strategy, clinical study design, and IND development.
We help emerging biotech teams integrate development evidence distributed across nonclinical, CMC, PK, clinical, and regulatory sources, identify critical gaps and unresolved questions, and translate that information into a decision and document foundation for advancing the Sponsor’s next development milestone.
AI-Assisted. Human-Led. Evidence-Grounded.
Many Development Problems Exist Before Drafting Begins.
In Sponsor-side clinical development, information often comes from multiple functional teams, external laboratories, CROs, and disciplines including CMC, pharmacology, toxicology, PK, clinical strategy, and regulatory documentation. These inputs are interconnected, but in practice they are often generated by different people, at different times, and handed off through different documents.
When these inputs are not sufficiently organized and connected upstream, critical issues may not become visible until protocol development, IND integration, CRO handoff, or even regulatory interaction.
That is why Onea Clinical Services does not begin with the question:
“How can we draft the document faster?”
We begin with a more fundamental question:
“Before committing to the next costly stage of development, have we clearly identified the issues that truly matter?”
Focused on Sponsor-Side Development Support—Not the Full Clinical Execution Chain
Onea Focuses On
-
Development Readiness & Gap Analysis
-
Pre-IND / FIH Strategy
-
Clinical Study Design
-
IND Development & Integration
-
Clinical / Regulatory Writing
-
Clinical Development Due Diligence
Onea Is Not Positioned As
-
A Full-Service CRO
-
A Site Management Organization
-
A Clinical Trial Execution Vendor
-
A Replacement for CMC, Toxicology, or Biostatistics Specialists
-
An eCTD Publishing or Regulatory Submission Provider
-
An AI Platform That Autonomously Makes Development Decisions for the Sponsor
In real-world Sponsor-side clinical development, development evidence and critical assumptions are often distributed across functional teams, external laboratories, and CROs. CMC, pharmacology, toxicology, PK, clinical strategy, and regulatory requirements are interconnected, but in practice they are often managed by different people, at different times, and across different documents.
Technology-Enabled, Human-Led
Onea integrates AI into evidence review, cross-document comparison, scenario analysis, and document workflows to broaden the scope of information that can be reviewed and improve consistency.
AI output is not evidence in itself, nor does it replace the professional judgment of the Sponsor or relevant specialists.
Onea Clinical is the clinical development professional services business of Onea Biotech Co., Ltd.
AI-Assisted Production · Clinical PM Integration · Human Professional Review
──────────────────────────────────────────────